Welcome to the age of reason, my friends.
In a bid to stop beta-testing vaccine variations on everyday citizens, the new Federal Drug Administration (FDA) leaders are rolling out rules that pharmaceutical companies need to actually prove the effectiveness of Covid boosters for people under 65 without co-morbidities using randomized clinical trials.
For people over 65 and with co-morbidities, the FDA says that there's ample evidence they have a healthy immune response from the boosters.
But for healthy young people, FDA Commissioner Marty Makary and top U.S. vaccines regulator Vinay Prasad wrote in the New England Journal of Medicine:
We simply don't know whether a healthy 52-year-old woman with a normal BMI who has had Covid-19 three times and has received six previous doses of a Covid-19 vaccine will benefit from the seventh dose. This policy will compel much-needed evidence generation.
Considering that randomized clinical trials would cost hundreds of millions of dollars and that the virus would most likely mutate long before those trials were completed, it may be time to force this meme into retirement.
Godspeed, ClotShot NPC.
You have served us well.
P.S. Now check out our latest video 👇
